,,ii #aaith ,,congress #b;d ,session ,s4 #echc ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,august #h 7legislative day1 ,august #g71 #bjbf,mr4 ,moreno introduced the following bill2 which was read twice and referred to the ,committee on the ,judiciary ,a ,,bill ,to amend the ,controlled ,substances ,act to schedule ,,mgm-#ae and ,,mgm-#af as ,schedule ,i ,controlled substances1 and to amend the controlled ,substances ,act to schedule synthetic #g-;hydroxymitragynine1 and ,mitragynine ,pseudoindoxyl1 as a ,schedule ,i above a specific threshold under the ,controlled ,substances ,act1 and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids1 commonly known as gas station heroin4 #a4 ,short title ,this ,act may be cited as the ,end ,gas ,station ,heroin ,act4 #b4 ,scheduling of #g-;hydroxymitragynine and mitragynine pseudoindoxyl ,schedule ,i of section #bjb7;c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7;c77 is amended1 in subsection 7b71 by adding at the end the following3 7#bc7 7,a7 #g-;hydroxymitragynine 7#g-,,oh7 and mitragynine pseudoindoxyl1 including their salts1 isomers1 salts of isomers1 esters1 ethers1 and synthetic analogs1 whenever the existence of such forms is possible4 7,b7 ,this paragraph shall not apply to #g-;hydroxymitragynine or mitragynine pseudoindoxyl naturally occurring in ,mitragyna speciosa ,korth 7kratom7 or in a finished kratom product1 provided that-- 7i7 in the case of a solid1 powdered1 or encapsulated product1 the concentration of #g-;hydroxymitragynine and mitragynine pseudoindoxyl1 individually or in combination1 does not exceed #a milligram per gram of product2 7ii7 in the case of a liquid product1 the concentration of #g-;hydroxymitragynine and mitragynine pseudoindoxyl1 individually or in combination1 does not exceed #a milligram per milliliter of product2 and 7iii7 the combined amount of #g-;hydroxymitragynine and mitragynine pseudoindoxyl1 including their salts1 isomers1 salts of isomers1 esters1 ethers1 and synthetic analogs1 does not exceed #a part per #ajj parts mitragynine by mass4 7,c7 ,for purposes of this paragraph1 any #g-;hydroxymitragynine or mitragynine pseudoindoxyl that is synthesized1 chemically converted1 concentrated1 enriched1 isolated1 or otherwise produced through manufacturing processes shall not qualify for the exemption described in subparagraph 7,b74 4 #c4 ,enforcement against emerging synthetic opioids in commercial distribution 7a7 ,treatment as a ,schedule ,i controlled substance ,notwithstanding any other provision of law1 a covered emerging synthetic opioid shall1 solely for purposes of prohibiting and enforcing against its knowing or intentional manufacture1 importation1 exportation1 distribution1 dispensing1 or possession with intent to manufacture1 import1 export1 distribute1 or dispense1 be treated as a controlled substance in ,schedule ,i of section #bjb7;c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7;c774 7b7 ,civil and criminal enforcement ,no person shall be subject under this section to criminal or civil enforcement based solely on the purchase1 receipt1 simple possession1 or personal use of a covered emerging synthetic opioid4 7c7 ,covered emerging synthetic opioid ,for purposes of this section1 the term covered emerging synthetic opioid means a substance that-- 7#a7 is being manufactured1 offered1 advertised1 sold1 distributed1 or otherwise introduced into commercial distribution1 or is intended by the person engaging in the prohibited conduct to be introduced into commercial distribution2 7#b7 is an opioid receptor agonist1 or partial agonist and1 based on scientifically reliable evidence1 demonstrates greater functional potency than morphine at the human mu-opioid receptor in a validated assay identified by regulation1 or demonstrates greater analgesic or respiratory-depressant potency than morphine based on other scientifically reliable evidence2 7#c7 is produced through chemical synthesis or semisynthesis2 7#d7 is not the subject of an approved application under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee72 7#e7 is intended for human consumption2 7#f7 is not otherwise listed in any schedule under section #bjb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab72 and 7#g7 is not excluded under subsection 7g74 7d7 ,covered conduct ,this section shall apply only to the knowing or intentional manufacture1 distribution1 or possession with intent to manufacture or distribute a covered emerging synthetic opioid4 7e7 ,no simple possession enforcement ,no person may be investigated1 arrested1 charged1 prosecuted1 or subjected to civil penalties under this section solely for simple possession or personal consumption of a covered emerging synthetic opioid4 ,nothing in this subsection shall prohibit enforcement based on possession with intent to manufacture1 distribute1 dispense1 import1 or export4 7f7 ,relationship to the controlled substance analogue enforcement act ,if a substance qualifies both as-- 7#a7 a controlled substance analogue under section #ajb7cb7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb7cb772 and 7#b7 a covered emerging synthetic opioid under this section1 the ,attorney ,general may proceed under section #bjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hac71 this section1 or any other applicable provision of ,federal law4 ,nothing in this section shall expand or limit the authority of a ,state attorney general or other ,state official under ,state law4 7g7 ,exclusions ,the term covered emerging synthetic opioid does not include-- 7#a7 a substance approved as a drug for medical treatment under the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq472 7#b7 a substance not intended for human consumption2 7#c7 a naturally occurring constituent of a plant1 fungus1 or other botanical material1 or a constituent derived through brewing or extraction process of a natural plant1 fungus1 or other botanical material1 unless the constituent has been intentionally1 isolated1 enriched1 concentrated1 chemically converted1 or added to a product for human consumption2 7#d7 a substance possessed or transferred solely for legitimate scientific1 medical1 forensic1 analytical1 or law-enforcement purposes2 or 7#e7 a substance otherwise exempted by the ,attorney ,general through regulation4 7h7 ,limitation to commercial conduct ,enforcement under this section may be based only on the quantity or portion of a substance that is-- 7#a7 introduced or intended to be introduced into commercial distribution2 and 7#b7 connected to conduct described in subsection 7a74 ,the presence of the same substance outside commercial distribution1 including possession for authorized research1 analytical testing1 forensic examination1 or other noncommercial purposes1 shall not independently subject that substance or conduct to enforcement under this section4 7i7 ,definitions ,for the purposes of this section-- 7#a7 the term commercial distribution means the advertisement1 offering for sale1 sale1 shipment1 transfer for value1 or distribution of a substance or product in or affecting interstate1 intrastate1 or foreign commerce2 7#b7 whether a substance is intended for human consumption shall be determined from all relevant facts and circumstances1 potentially including labeling1 advertising1 dosage form1 method of sale1 representations by the seller1 customary use1 and evidence concerning the intended market2 7#c7 the term scientifically reliable evidence includes validated in vitro1 animal1 human1 pharmacokinetic1 pharmacodynamic1 receptor-binding1 functional-activity1 or other scientifically accepted evidence identified by the ,attorney ,general1 in consultation with the ,secretary of ,health and ,human ,services2 and 7#d7 the term semisynthesis means the chemical modification or conversion of a naturally occurring substance into a chemically distinct substance4